phactMI, a 501 (c)(6) corporation, is a collaboration of Medical Information leaders from the pharmaceutical industry. These Medical Information professionals provide accurate and unbiased clinical data on their products that facilitates the safe and effective use of medicines. How and why was phactMI created?

Join us in this episode as Evelyn Hermes-DeSantis, PharmD, BCPS, Director, Research and Publications, phactMI/ Professor Emerita, Rutgers, The State University of New Jersey and guest speakers Patrick Reilly, PA, CEO, phactMI and Mary Sendi, North America Medical Information Regional Lead Pfizer/ President phactMI discuss medical information, the role of manufacturers in providing scientifically accurate information, and the genesis of phactMI.

Learn more about phactMI at www.phactMI.org/about/

Follow phactMI on LinkedIn, Facebook, and Twitter

References:

phactMI. About phactMI. www.phactMI.org/about. Accessed November 10, 2021.

Hermes-DeSantis ER, Johnson RM, Redlich A, et al. Proposed best practice guidelines for scientific response documents: a consensus statement from phactMI. Ther Innov Regul Sci. 2020;54:1303-11.

Rai R, Hermes-DeSantis ER, phactMI. Healthcare professional’s opinions on an endorsement tool for scientific response documents developed by pharmaceutical companies. phactMI Internal Data. Presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting. 2019.

phactMI. Code of practice. www.phactMI.org/code-of-practice. Accessed November 10, 2021.

Learn more about your ad choices. Visit megaphone.fm/adchoices